GP Pharm And Prostate Cancer

GP Pharm is a pharmaceutical company that undertakes contract manufacturing as well as the pharmaceutical and clinical development of urology and oncology products.  It is part of the Lipotec Group and specialises in the manufacture of proprietary controlled release and encapsulated products. The company also takes on a wide range of contract manufacturing projects.

Gp Pharm develops and manufactures injectable cytotoxics in solution or freeze-dried forms.

GP Pharm's Proprietary Pharmaceutical Solutions Including GP Pharm's Prostate Cancer Products

GP Pharm is at the cutting-edge of proprietary urology and oncology product development including products for the treatment of prostate cancer.

The company has projects developing microspheres and liposomes, and coated adhesive microparticles.

The company has recently set up a new manufacturing facility for the development of injectable products in Barcelona. These facilities consist of three independent manufacturing buildings that specialise in finished dosage forms of highly potent APIs including encapsulated and liposomal formulations and cytoxic materials.

GP Pharm's headquarters is based in Gavà, close to Barcelona's airport.

More information about GP Pharm and it's prostate cancer products can be found at the company web site at

URL: http://www.gp-pharm.com/